title: Focus on hepatitis. Weight-based RBV dosing = impressive treatment success rates.
authors.forename: Gus
authors.initials: G
authors.lastname: Cairns
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin